Reutericyclin, a specialized metabolite of Limosilactobacillus reuteri, mitigates risperidone-induced weight gain in mice

The role of xenobiotic disruption of microbiota, corresponding dysbiosis, and potential links to host metabolic diseases are of critical importance. In this study, we used a widely prescribed antipsychotic drug, risperidone, known to influence weight gain in humans, to induce weight gain in C57BL/6J...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Fatima A. Aboulalazm, Alexis B. Kazen, Orlando deLeon, Susanne Müller, Fatima L. Saravia, Valery Lozada-Fernandez, Matthew A. Hadiono, Robert F. Keyes, Brian C. Smith, Stephanie L. Kellogg, Justin L. Grobe, Tammy L. Kindel, John R. Kirby
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Taylor & Francis Group 2025-12-01
Sarja:	Gut Microbes
Aiheet:	Risperidone reutericyclin anti-obesogenic energy balance Limosilactobacillus reuteri random forest
Linkit:	https://www.tandfonline.com/doi/10.1080/19490976.2025.2477819
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!